Dataset of phase I and II immunotherapy clinical trials used for a meta-analysis to assess the role of biomarkers in treatment outcomes in diverse cancers

We performed a literature search in PubMed to identify phase I/II clinical trials with immunotherapy drugs approved by the Food and Drug Administration (labeled, off-label, and/or combined with investigational immune checkpoint inhibitors or other treatment modalities) from 2018 to 2020. We used the...

Descripción completa

Detalles Bibliográficos
Autores principales: Fountzilas, Elena, Hiep Vo, Henry, Mueller, Peter, Kurzrock, Razelle, Tsimberidou, Apostolia-Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Data Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630619/
https://www.ncbi.nlm.nih.gov/pubmed/38020439
http://dx.doi.org/10.1016/j.dib.2023.109698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630619/
https://www.ncbi.nlm.nih.gov/pubmed/38020439
http://dx.doi.org/10.1016/j.dib.2023.109698

Ejemplares similares